Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?

By Casper Robert F.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1144-1146

Oxford University Press

Access to resources Recommend Favorite

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite

Treatment of ovarian hyperstimulation syndrome using gonadotropin releasing hormone antagonist: a pilot study

By Hosseini Marzieh Agha   Mahdavi Atossa   Aleyasin Ashraf   Safdarian Leili   Bahmaee Fatemeh  

Gynecological Endocrinology, Vol. 28, Iss. 11, 2012-11 ,pp. : 853-855

Informa Healthcare

Access to resources Recommend Favorite

Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation

By Orvieto Raoul   Zagatsky Irina   Yulzari-Roll Vered   la Marca Antonio   Fisch Benjamin  

Gynecological Endocrinology, Vol. 22, Iss. 8, 2006-08 ,pp. : 437-440

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite